These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 16612219

  • 1. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
    Chen G, Manji HK.
    Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219
    [Abstract] [Full Text] [Related]

  • 2. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK, Duman RS.
    Psychopharmacol Bull; 2001 May; 35(2):5-49. PubMed ID: 12397885
    [Abstract] [Full Text] [Related]

  • 3. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
    Einat H, Manji HK.
    Biol Psychiatry; 2006 Jun 15; 59(12):1160-71. PubMed ID: 16457783
    [Abstract] [Full Text] [Related]

  • 4. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
    Gray NA, Zhou R, Du J, Moore GJ, Manji HK.
    J Clin Psychiatry; 2003 Jun 15; 64 Suppl 5():3-17. PubMed ID: 12720479
    [Abstract] [Full Text] [Related]

  • 5. The extracellular signal-regulated kinase pathway may play an important role in mediating antidepressant-stimulated hippocampus neurogenesis in depression.
    Wang L, Peng D, Xie B, Jiang K, Fang Y.
    Med Hypotheses; 2012 Jul 15; 79(1):87-91. PubMed ID: 22546758
    [Abstract] [Full Text] [Related]

  • 6. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G.
    J Clin Psychiatry; 1999 Jul 15; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [Abstract] [Full Text] [Related]

  • 7. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.
    Manji HK, Moore GJ, Chen G.
    Br J Psychiatry Suppl; 2001 Jun 15; 41():s107-19. PubMed ID: 11450170
    [Abstract] [Full Text] [Related]

  • 8. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
    Manji HK, Chen G.
    Mol Psychiatry; 2002 Jun 15; 7 Suppl 1():S46-56. PubMed ID: 11986995
    [Abstract] [Full Text] [Related]

  • 9. Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.
    Quiroz JA, Singh J, Gould TD, Denicoff KD, Zarate CA, Manji HK.
    Mol Psychiatry; 2004 Aug 15; 9(8):756-76. PubMed ID: 15136795
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
    Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK.
    Mol Psychiatry; 2004 Aug 15; 9(8):734-55. PubMed ID: 15136794
    [Abstract] [Full Text] [Related]

  • 12. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.
    Gould TD, Zarate CA, Manji HK.
    J Clin Psychiatry; 2004 Jan 15; 65(1):10-21. PubMed ID: 14744163
    [Abstract] [Full Text] [Related]

  • 13. [Glia as targets for antidepressants: an involvement in glial cell line-derived neurotrophic factor].
    Hisaoka K, Takebayashi M.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Nov 15; 27(5-6):173-9. PubMed ID: 18154038
    [Abstract] [Full Text] [Related]

  • 14. [Quetiapin in bipolar disorders].
    Sümegi A.
    Neuropsychopharmacol Hung; 2008 Dec 15; 10(5):281-91. PubMed ID: 19419014
    [Abstract] [Full Text] [Related]

  • 15. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis.
    Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P, Gould TD, Manji HK, Chen G.
    J Neurosci; 2004 Jul 21; 24(29):6590-9. PubMed ID: 15269271
    [Abstract] [Full Text] [Related]

  • 16. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Hamrin V, Pachler M.
    J Child Adolesc Psychiatr Nurs; 2007 Feb 21; 20(1):40-58. PubMed ID: 17284237
    [Abstract] [Full Text] [Related]

  • 17. Analysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): identification of extracellular signal-regulated kinase-controlled genes.
    Salzmann J, Canestrelli C, Noble F, Marie-Claire C.
    Neuroscience; 2006 Feb 21; 137(2):473-82. PubMed ID: 16289835
    [Abstract] [Full Text] [Related]

  • 18. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP, Valvassori SS, Dal-Pont GC, Quevedo J.
    Curr Drug Metab; 2018 Feb 21; 19(8):663-673. PubMed ID: 29283064
    [Abstract] [Full Text] [Related]

  • 19. Brain creatine kinase activity in an animal model of mania.
    Streck EL, Amboni G, Scaini G, Di-Pietro PB, Rezin GT, Valvassori SS, Luz G, Kapczinski F, Quevedo J.
    Life Sci; 2008 Feb 13; 82(7-8):424-9. PubMed ID: 18191157
    [Abstract] [Full Text] [Related]

  • 20. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.
    Zarate CA, Singh J, Manji HK.
    Biol Psychiatry; 2006 Jun 01; 59(11):1006-20. PubMed ID: 16487491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.